Exact Mass: 475.37523680000004
Exact Mass Matches: 475.37523680000004
Found 54 metabolites which its exact mass value is equals to given mass value 475.37523680000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(7Z,10Z,13Z,16Z)-Docosatetraenoylcarnitine
C29H49NO4 (475.36613940000007)
(7Z,10Z,13Z,16Z)-Docosatetraenoylcarnitine is an acylcarnitine. More specifically, it is an (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (7Z,10Z,13Z,16Z)-Docosatetraenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (7Z,10Z,13Z,16Z)-Docosatetraenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Adrenoylcarnitine
C29H49NO4 (475.36613940000007)
2-tetracosanamidoethanesulfonic acid
C26H53NO4S (475.36950980000006)
CAR 22:4
C29H49NO4 (475.36613940000007)
(2-hydroxyethyl)dimethyl[3-[(1-oxooctadecyl)amino]propyl]ammonium nitrate
1-[bis(2-hydroxypropyl)amino]propan-2-ol,octadecanoic acid
C27H57NO5 (475.42365120000005)
(10Z,13Z,16Z,19Z)-N-(1,3-dihydroxyoctan-2-yl)docosa-10,13,16,19-tetraenamide
C30H53NO3 (475.40252280000004)
(10Z,13Z,16Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]docosa-10,13,16-trienamide
C30H53NO3 (475.40252280000004)
(9Z,12Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]octadeca-9,12-dienamide
C30H53NO3 (475.40252280000004)
(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxydodecan-2-yl)octadeca-6,9,12,15-tetraenamide
C30H53NO3 (475.40252280000004)
(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]hexadec-9-enamide
C30H53NO3 (475.40252280000004)
(8Z,11Z,14Z,17Z)-N-(1,3-dihydroxydecan-2-yl)icosa-8,11,14,17-tetraenamide
C30H53NO3 (475.40252280000004)
(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]hexadeca-7,10,13-trienamide
C30H53NO3 (475.40252280000004)
(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxytetradecan-2-yl)hexadeca-4,7,10,13-tetraenamide
C30H53NO3 (475.40252280000004)
(9Z,12Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]heptadeca-9,12-dienamide
C30H53NO3 (475.40252280000004)
(Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]tridec-9-enamide
C30H53NO3 (475.40252280000004)
(9Z,12Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]hexadeca-9,12-dienamide
C30H53NO3 (475.40252280000004)
(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]octadeca-9,12,15-trienamide
C30H53NO3 (475.40252280000004)
(11Z,14Z,17Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]icosa-11,14,17-trienamide
C30H53NO3 (475.40252280000004)
(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-ene-1-sulfonic acid
C25H49NO5S (475.3331264000001)
3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecane-1-sulfonic acid
C25H49NO5S (475.3331264000001)
(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-ene-1-sulfonic acid
C25H49NO5S (475.3331264000001)
(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-ene-1-sulfonic acid
C25H49NO5S (475.3331264000001)
3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decane-1-sulfonic acid
C25H49NO5S (475.3331264000001)
(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-ene-1-sulfonic acid
C25H49NO5S (475.3331264000001)
(E)-2-(decanoylamino)-3-hydroxypentadec-4-ene-1-sulfonic acid
C25H49NO5S (475.3331264000001)
(E)-2-(dodecanoylamino)-3-hydroxytridec-4-ene-1-sulfonic acid
C25H49NO5S (475.3331264000001)
3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecane-1-sulfonic acid
C25H49NO5S (475.3331264000001)
(Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]tetradec-9-enamide
C30H53NO3 (475.40252280000004)
(Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]pentadec-9-enamide
C30H53NO3 (475.40252280000004)
(Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]dodec-5-enamide
C30H53NO3 (475.40252280000004)
(Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]tridec-8-enamide
C30H53NO3 (475.40252280000004)
(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]hexadec-7-enamide
C30H53NO3 (475.40252280000004)
(4Z,7Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]hexadeca-4,7-dienamide
C30H53NO3 (475.40252280000004)
(7Z,10Z,13Z,16Z)-docosatetraenoylcarnitine
C29H49NO4 (475.36613940000007)
An O-acylcarnitine having (7Z,10Z,13Z,16Z)-docosatetraenoyl as the acyl substituent.
N-tetracosanoyltaurine
C26H53NO4S (475.36950980000006)
A fatty acid-taurine conjugate derived from tetracosanoic acid.
Cer(30:4)
C30H53NO3 (475.40252280000004)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2r,3s,4r,6s)-6-{[(1s,2r,5s,7s,10r,11r,14r,17s,18s)-10,17-dimethyl-16,21-dioxahexacyclo[15.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁸]henicosan-7-yl]oxy}-4-methoxy-2-methyloxan-3-amine
C28H45NO5 (475.32975600000003)